Infectious toxicities associated with bispecific antibodies and CAR-T Cells in multiple myeloma: a systematic review

Magdalena Benda, Patrick Reimann, Wolfgang Willenbacher, Eberhard Gunsilius, Katja Weisel, Irene Strassl, Maria Theresa Krauth, Stefan Knop, Thomas Winder, Normann Steiner · 2026

Read Infectious toxicities associated with bispecific antibodies and CAR-T Cells in multiple myeloma: a systematic review by Magdalena Benda, Patrick Reimann, Wolfgang Willenbacher, Eberhard Gunsilius, Katja Weisel, Irene Strassl, Maria Theresa Krauth, Stefan Knop, Thomas Winder, Normann Steiner (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13521976.txt.

Description

Magdalena Benda and colleagues review in 2026 infection risk from T-cell redirecting cures for relapsed myeloma. The set held 123 studies, mostly early phase. Cures cover engineered CAR T cells and bispecific antibodies. These cures changed care, yet infection load stays high.

Any-grade infection rates ran from about 40 to 80 percent in most reports. Risk peaked early after cell dosing or in early antibody months. Severe infection topped half in some antibody groups. Fatal cases arose under both cure types. Viruses and bacteria led the germ lists. Fungal disease and one pneumonia type arose where preventive cover was absent.

Catalog record

CREATORMagdalena Benda, Patrick Reimann, Wolfgang Willenbacher, Eberhard Gunsilius, Katja Weisel, Irene Strassl, Maria Theresa Krauth, Stefan Knop, Thomas Winder, Normann Steiner
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53254
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13521976

Browse the full library · About the Tower of Babel